Nanoform Is A Finnish Company That Specializes In Nanoparticle Medicine Enabling Technologies To Enhance Pharmaceutical Formulationsfounded In 2012With Roots In Technology Development At The University Of Helsinki Since 2008Nanoform Went Public In 2020 On The Nasdaq First North Growth Marketthe Company Is Headquartered In Helsinki And Focuses On Improving Drug Bioavailability And Clinical Trial Success Rates Through Its Proprietary Nanotechnology Nanoform Offers Patented Cessatechnologywhich Produces Nanoformed Active Pharmaceutical Ingredientapiparticles As Small As 10 Nmthis Technology Addresses Low Solubility Issuesenhancing Dissolution Rates And Bioavailabilitythe Company Also Provides Tailored Nanoforminga C Services For Pharmaceutical And Biotech Partners To Optimize Drug Formulations For Various Delivery Routesadditionallynanoform Has Initiated Good Manufacturing Practicegmpprojects To Support Clinical Trials And Commercializationtargeting Global Pharmaceutical And Biotech Companies To Advance Drug Development
Cphi Frankfurt
Germany
28 Oct 2025
6
A2
| Company Name | Nanoform Finland Oyj |
| Country |
Finland
|
| Address | Viikinkaari 4 00790 Helsinki Finland |
| Telephone | Login to View |
| Login to View |
